Cipla gets USFDA nod for generic product

The company has received final approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Novartis Pharmaceutical Corporation#39;#39;s Durezol, Cipla said in a statement.

from Moneycontrol Business News https://ift.tt/2VIue1A